Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 1/2019

01-02-2019 | Original Article

Evaluation of factors affecting time to achieve dry weight among hemodialysis patients using bioimpedance spectroscopy

Authors: Amjad Khan, Amer Hayat Khan, Azreen Syazril Adnan, Syed Azhar Syed Sulaiman, Nafees Ahmad, Siew Hua Gan

Published in: Irish Journal of Medical Science (1971 -) | Issue 1/2019

Login to get access

Abstract

Background

Achieving and maintaining dry weight appears to be an effective strategy for controlling and maintaining normotension among hypertensive patients on hemodialysis (HD).

Objective

The present study aimed to determine the time at which the majority of patients achieve postdialysis dry weight using bioimpedance spectroscopy (BIS).

Methods

A total of 220 HD patients were prospectively assessed for fluid overload using the Fresenius body composition monitor (BCM). BCM readings were taken at 30 and 45 min postdialysis.

Results

Among the 220 patients included in this study, 120 (54.5%) achieved a euvolemic state at 30 min, and 25 (11.4%) achieved it at 45 min according to the BCM. In the multivariate analysis, vascular access other than arteriovenous fistula (AVF) (OR = 0.286, p value = 0.049) and cardiovascular disease (OR = 0.384, p value = 0.026) had a statistically significant negative association and receiving HD at Hospital Universiti Sains Malaysia (HUSM) (OR = 2.705, p value = 0.008) had a statistically significant positive association with achieving a euvolemic state at 30 min.

Conclusion

This suggests that assessing the hydration status at 45 min postdialysis in all patients or in those with identified risk factors for not achieving a euvolemic state at 30 min will provide a relatively accurate assessment for most patients.
Literature
1.
go back to reference Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB et al (2009) Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 119:671–679CrossRefPubMedPubMedCentral Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB et al (2009) Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 119:671–679CrossRefPubMedPubMedCentral
3.
go back to reference Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C et al (2009) The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 24:1574–1579CrossRefPubMedPubMedCentral Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C et al (2009) The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 24:1574–1579CrossRefPubMedPubMedCentral
4.
go back to reference Chazot C, Wabel P, Chamney P, Moissl U, Wieskotten S, Wizemann V (2012) Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial Transplant 27:2404–2410CrossRefPubMed Chazot C, Wabel P, Chamney P, Moissl U, Wieskotten S, Wizemann V (2012) Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial Transplant 27:2404–2410CrossRefPubMed
5.
go back to reference Odudu A, McIntyre C (2012) Volume is not the only key to hypertension control in dialysis patients. Nephron Clin Pract 120:c173–c177CrossRefPubMed Odudu A, McIntyre C (2012) Volume is not the only key to hypertension control in dialysis patients. Nephron Clin Pract 120:c173–c177CrossRefPubMed
7.
go back to reference Covic A, Onofriescu M (2013) Time to improve fluid management in hemodialysis: should we abandon clinical assessment and routinely use bioimpedance? Clin J Am Soc Nephrol 8:1474–1475CrossRefPubMedPubMedCentral Covic A, Onofriescu M (2013) Time to improve fluid management in hemodialysis: should we abandon clinical assessment and routinely use bioimpedance? Clin J Am Soc Nephrol 8:1474–1475CrossRefPubMedPubMedCentral
8.
go back to reference Agarwal R, Weir MR (2010) Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol 5:1255–1260CrossRefPubMedPubMedCentral Agarwal R, Weir MR (2010) Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol 5:1255–1260CrossRefPubMedPubMedCentral
9.
go back to reference Dolgos S, Hartmann A, Bollerslev J, Vörös P, Rosivall L (2011) The importance of body composition and dry weight assessments in patients with chronic kidney disease (review). Acta Physiol Hung 98:105–116CrossRefPubMed Dolgos S, Hartmann A, Bollerslev J, Vörös P, Rosivall L (2011) The importance of body composition and dry weight assessments in patients with chronic kidney disease (review). Acta Physiol Hung 98:105–116CrossRefPubMed
10.
go back to reference Machek P, Jirka T, Moissl U, Chamney P & Wabel P (2009) Guided optimization of fluid status in haemodialysis patients. Nephrol Dial Transplant gfp487 Machek P, Jirka T, Moissl U, Chamney P & Wabel P (2009) Guided optimization of fluid status in haemodialysis patients. Nephrol Dial Transplant gfp487
11.
go back to reference Chongthanakorn K, Tiranathanagul K, Susantitaphong P, Praditpornsilpa K, Eiam-Ong S (2009) Effective determination of dry weight by intradialytic bioimpedance analysis in hemodialysis. Blood Purif 27:235–241CrossRefPubMed Chongthanakorn K, Tiranathanagul K, Susantitaphong P, Praditpornsilpa K, Eiam-Ong S (2009) Effective determination of dry weight by intradialytic bioimpedance analysis in hemodialysis. Blood Purif 27:235–241CrossRefPubMed
12.
go back to reference Kotanko P, Levin NW, Zhu F (2008) Current state of bioimpedance technologies in dialysis. Nephrol Dial Transplant 23:808–812CrossRefPubMed Kotanko P, Levin NW, Zhu F (2008) Current state of bioimpedance technologies in dialysis. Nephrol Dial Transplant 23:808–812CrossRefPubMed
13.
go back to reference Chamney PW, Krämer M, Rode C, Kleinekofort W, Wizemann V (2002) A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int 61:2250–2258CrossRefPubMed Chamney PW, Krämer M, Rode C, Kleinekofort W, Wizemann V (2002) A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int 61:2250–2258CrossRefPubMed
14.
go back to reference Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P et al (2008) Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 23:2965–2971CrossRefPubMed Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P et al (2008) Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 23:2965–2971CrossRefPubMed
15.
go back to reference Park J, Yang WS, Kim SB, Park S-K, Lee SK, Park JS et al (2008) Usefulness of segmental bioimpedance ratio to determine dry body weight in new hemodialysis patients: a pilot study. Am J Nephrol 29:25–30CrossRefPubMed Park J, Yang WS, Kim SB, Park S-K, Lee SK, Park JS et al (2008) Usefulness of segmental bioimpedance ratio to determine dry body weight in new hemodialysis patients: a pilot study. Am J Nephrol 29:25–30CrossRefPubMed
16.
go back to reference Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH (2016) Chronic kidney disease, fluid overload and diuretics: a complicated triangle. PLoS One 11:e0159335CrossRefPubMedPubMedCentral Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH (2016) Chronic kidney disease, fluid overload and diuretics: a complicated triangle. PLoS One 11:e0159335CrossRefPubMedPubMedCentral
17.
go back to reference Devolder I, Verleysen A, Vijt D, Vanholder R, Van Biesen W (2010) Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients. Perit Dial Int 30:208–214CrossRefPubMed Devolder I, Verleysen A, Vijt D, Vanholder R, Van Biesen W (2010) Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients. Perit Dial Int 30:208–214CrossRefPubMed
18.
go back to reference Wabel P, Chamney P, Moissl U, Jirka T (2009) Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif 27:75–80CrossRefPubMedPubMedCentral Wabel P, Chamney P, Moissl U, Jirka T (2009) Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif 27:75–80CrossRefPubMedPubMedCentral
19.
go back to reference Wizemann V, Rode C, Wabel P (2008) Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients. In: Hemodialysis—from basic research to clinical trials. Contrib Nephrol 161:115–118CrossRefPubMed Wizemann V, Rode C, Wabel P (2008) Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients. In: Hemodialysis—from basic research to clinical trials. Contrib Nephrol 161:115–118CrossRefPubMed
20.
go back to reference Moissl U, Arias-Guillén M, Wabel P, Fontseré N, Carrera M, Campistol JM, et al. (2013) Bioimpedance-guided fluid management in hemodialysis patients. Clin J Am Soc Nephrol 12411212 Moissl U, Arias-Guillén M, Wabel P, Fontseré N, Carrera M, Campistol JM, et al. (2013) Bioimpedance-guided fluid management in hemodialysis patients. Clin J Am Soc Nephrol 12411212
21.
go back to reference Chen H-S, Lee K-C, Cheng C-T, Hou C-C, Liou H-H, Lin C-J et al (2012) Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD): serial follow-up and dry weight evaluation. Clin Kidney J 6:29–34CrossRefPubMedPubMedCentral Chen H-S, Lee K-C, Cheng C-T, Hou C-C, Liou H-H, Lin C-J et al (2012) Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD): serial follow-up and dry weight evaluation. Clin Kidney J 6:29–34CrossRefPubMedPubMedCentral
22.
go back to reference Siriopol D et al (2013) Predicting mortality in haemodialysis patients: a comparison between lung ultrasonography, bioimpedance data and echocardiography parameters. Nephrol Dial Transplant gft260 Siriopol D et al (2013) Predicting mortality in haemodialysis patients: a comparison between lung ultrasonography, bioimpedance data and echocardiography parameters. Nephrol Dial Transplant gft260
23.
go back to reference Siriopol D, Hogas S, Voroneanu L, Onofriescu M, Apetrii M, Oleniuc M et al (2013) Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas 27:921 Siriopol D, Hogas S, Voroneanu L, Onofriescu M, Apetrii M, Oleniuc M et al (2013) Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas 27:921
24.
go back to reference Wieskotten S, Heinke S, Wabel P, Moissl U, Becker J, Pirlich M et al (2008) Bioimpedance-based identification of malnutrition using fuzzy logic. Physiol Meas 29:639CrossRefPubMed Wieskotten S, Heinke S, Wabel P, Moissl U, Becker J, Pirlich M et al (2008) Bioimpedance-based identification of malnutrition using fuzzy logic. Physiol Meas 29:639CrossRefPubMed
25.
go back to reference Tai R, Ohashi Y, Mizuiri S, Aikawa A, Sakai K (2014) Association between ratio of measured extracellular volume to expected body fluid volume and renal outcomes in patients with chronic kidney disease: a retrospective single-center cohort study. BMC Nephrol 15:189CrossRefPubMedPubMedCentral Tai R, Ohashi Y, Mizuiri S, Aikawa A, Sakai K (2014) Association between ratio of measured extracellular volume to expected body fluid volume and renal outcomes in patients with chronic kidney disease: a retrospective single-center cohort study. BMC Nephrol 15:189CrossRefPubMedPubMedCentral
26.
go back to reference Van Biesen W, Williams JD, Covic AC, Fan S, Claes K, Lichodziejewska-Niemierko M et al (2011) Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort. PLoS One 6:e17148CrossRefPubMedPubMedCentral Van Biesen W, Williams JD, Covic AC, Fan S, Claes K, Lichodziejewska-Niemierko M et al (2011) Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort. PLoS One 6:e17148CrossRefPubMedPubMedCentral
27.
go back to reference Kuhlmann MK, Zhu F, Seibert E, Levin NW (2005) Bioimpedance, dry weight and blood pressure control: new methods and consequences. Curr Opin Nephrol Hypertens 14:543–549CrossRefPubMed Kuhlmann MK, Zhu F, Seibert E, Levin NW (2005) Bioimpedance, dry weight and blood pressure control: new methods and consequences. Curr Opin Nephrol Hypertens 14:543–549CrossRefPubMed
28.
go back to reference National Kidney Foundation (NKF) (2006) KDOQI clinical practice guidelines and clinical practice recommendations for 2006. Updates: Hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 48:S1–S322CrossRef National Kidney Foundation (NKF) (2006) KDOQI clinical practice guidelines and clinical practice recommendations for 2006. Updates: Hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 48:S1–S322CrossRef
29.
go back to reference Joseph SM, Cedars AM, Ewald GA, Geltman EM, Mann DL (2009) Acute decompensated heart failure. Tex Heart Inst J 36:510–520PubMedPubMedCentral Joseph SM, Cedars AM, Ewald GA, Geltman EM, Mann DL (2009) Acute decompensated heart failure. Tex Heart Inst J 36:510–520PubMedPubMedCentral
Metadata
Title
Evaluation of factors affecting time to achieve dry weight among hemodialysis patients using bioimpedance spectroscopy
Authors
Amjad Khan
Amer Hayat Khan
Azreen Syazril Adnan
Syed Azhar Syed Sulaiman
Nafees Ahmad
Siew Hua Gan
Publication date
01-02-2019
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2019
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-018-1813-2

Other articles of this Issue 1/2019

Irish Journal of Medical Science (1971 -) 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine